EP3509591
NÝIR JAK1 SÉRTÆKIR HEMLAR OG NOTKUN ÞEIRRA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.9.2017EP published:
17.11.2021EP application number:
17858944.6
EP translation filed:
17.12.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
29.9.2037Expiry date:
29.9.2026Next due date:
30.9.2026
Title in English:
NOVEL JAK1 SELECTIVE INHIBITORS AND USES THEREOFLanguage of the patent:
English
Timeline
Today
30.9.2017EP application
17.11.2021EP Publication
17.12.2021Translation submitted
15.1.2022Registration published
29.9.2026Expires
Owner
Name:
Hangzhou Highlightll Pharmaceutical Co., Ltd.Address:
RM 301/302, Building 4, Hexiang Science & Technology Center, Qiantang District, Hangzhou, Zhejian 310018, CN
Inventor
Name:
LIANG, CongxinAddress:
Palm Beach Gardens, FL 33410, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201662403660 PDate:
3.10.2016Country:
US
Classification
Categories:
C07D 491/147, C07D 491/048, A61K 31/437, A61P 19/02, A61K 31/4155, A61K 31/519
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 18.8.2022
Expires: 29.9.2023
Payer: Acumass
Number: 7
Paid: 19.9.2023
Expires: 29.9.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 17.9.2024
Expires: 29.9.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 17.9.2025
Expires: 29.9.2026
Payer: Árnason Faktor ehf.